Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy?

Patients with gastroesophageal reflux disease (GERD) are routinely treated with proton pump inhibitors (PPIs), despite many reports of increased fracture risk associated with PPI use. Notably, the skeletal properties in patients with GERD prior to PPI therapy have not been addressed. We hypothesized...

Descripción completa

Detalles Bibliográficos
Autores principales: Aasarød, Kristin M., Mosti, Mats P., Finstad, Malin T., Stunes, Astrid K., Fossmark, Reidar, Syversen, Unni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167151/
https://www.ncbi.nlm.nih.gov/pubmed/34095362
http://dx.doi.org/10.1016/j.bonr.2021.101095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167151/
https://www.ncbi.nlm.nih.gov/pubmed/34095362
http://dx.doi.org/10.1016/j.bonr.2021.101095

Ejemplares similares